Decision Diagnostics Corp (DECN)

[Leirum]

Based on a report from marketresearch.com from January 2012,
J&J covers 27 % of the worldmarket. Based on figures from 2010 the size for Global Blood Glucose Monitoring Devises was 9 Billion, from this 4 Billion in the USA. Roche and Life Scan combined share of more than 50 %.
If DECN can grap from the worldwide market 3 % or from the USA market 5 % we are talking 270 Mio or 200 Mio in Revenues. The marketpotential is so huge, that DECN has excellent chances to achieve this kind of revenues without being called too optimistic. Of course this is not an overnight story in the selling pit but possible within 2 years. J&J would better stop fighting them and make a decent offer.